We Offer Worldwide Shipping
Login Wishlist

Erlotinib hydrochloride

$82

  • Brand : BIOFRON

  • Catalogue Number : BN-O1228

  • Specification : 98%(HPLC)

  • CAS number : 183319-69-9

  • Formula : C22H24ClN3O4

  • Molecular Weight : 429.9

  • PUBCHEM ID : 176871

  • Volume : 5mg

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BN-O1228

Analysis Method

Specification

98%(HPLC)

Storage

-20℃

Molecular Weight

429.9

Appearance

Powder

Botanical Source

Structure Type

Category

SMILES

COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl

Synonyms

Erlotonid HCl/Erlotinib hydrochloride/Erlotinib-d6 HCl/ERLOTINIB HCL SALT/CP-358774-01/Erlotinib Hydrochloride Salt/N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride/4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)/Hydrogen chloride - N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine (1:1:1)/Tarceva/N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride (1:1)/N-(3-Ethinylphenyl)-6,7-bis(2-methoxyethoxy)chinazolin-4-aminhydrochlorid/OSI 774/Erlotinib,OS-774/Erlotinib (Hydrochloride)/Erlotinib HCl

IUPAC Name

Density

Solubility

Flash Point

288.6ºC

Boiling Point

553.6ºC at 760 mmHg

Melting Point

223-225ºC

InChl

InChl Key

GTTBEUCJPZQMDZ-UHFFFAOYSA-N

WGK Germany

RID/ADR

HS Code Reference

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:183319-69-9) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

26120651

Title

[Oligoprogression]

Author

Matthias Guckenberger 1

Publish date

May-15

PMID

29429508

Abstract

Over the last year there has been major publications related to therapeutic trials in infectious dermatology, not only with regard to Herpes zoster subunit vaccine but also for the treatment of uncomplicated abscesses or scabies. In addition, biological treatments continue to be on the forefront, not only in the treatment of psoriasis but also in other chronic inflammatory dermatologic diseases such as atopic dermatitis and hidradenitis suppurativa, two diseases that significantly impact quality of life and for which there are to date, few therapeutic alternatives in moderate to severe forms. In addition, the treatment of cyclin-resistant papulopustular rosacea was also the subject of a large French controlled randomized controlled trial that could modify our therapeutic approach by the use of isotretinoin. Finally, the prevention of rashes induced by erlotinib with oral doxycyline is also part of this 2016 “what’s new in dermatological therapeutics”.

KEYWORDS

Abcess; Abces; Atopic dermatitis; Dermatite atopique; Erlotinib; Exantheme; Gale; Hidradenitis suppurativa; Hidradenite suppuree; Psoriasis; Rash; Rosacea; Rosacee; Scabies; Therapeutic; Therapeutique.

Title

[What's New in Dermatological Therapy?]

Author

K Ezzedine 1

Publish date

2016 Dec

PMID

29735378

Title

More Is More? Pushing Chemoradiotherapy of Oesophageal Squamous Cell Carcinoma Forward

Author

Florian Lordick 1

Publish date

2018 Jul;


Description :

Empty ...